SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000850261-19-000029
Filing Date
2019-08-09
Accepted
2019-08-09 16:49:34
Documents
90
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q srne06301910-q.htm   iXBRL 10-Q 1975376
2 EXHIBIT 31.1 exhibit311063019.htm EX-31.1 12308
3 EXHIBIT 31.2 exhibit312063019.htm EX-31.2 12122
4 EXHIBIT 32.1 exhibit321063019.htm EX-32.1 13198
  Complete submission text file 0000850261-19-000029.txt   9703841

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srne-20190630.xsd EX-101.SCH 68201
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srne-20190630_cal.xml EX-101.CAL 111520
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srne-20190630_def.xml EX-101.DEF 434056
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srne-20190630_lab.xml EX-101.LAB 875202
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srne-20190630_pre.xml EX-101.PRE 572723
10 EXTRACTED XBRL INSTANCE DOCUMENT srne06301910-q_htm.xml XML 1652442
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 191013556
SIC: 8731 Services-Commercial Physical & Biological Research